ATR Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2026Q1

FY2026Q2

880.21M

+3.79%

1.236

-18.7%

933.72M

+5.23%

1.213

+1.11%

985.58M

+2.03%

1.490

-10.24%

Estimates Revision

The market is revising Downward the revenue expectations for AptarGroup, Inc. (ATR) for FY2025, with the revenue forecasts being adjusted by -0.32% over the past three months. During the same period, the stock price has changed by -5.41%.

Revenue Estimates for FY2025

Revise Downward

-0.32%

In Past 3 Month

EPS Estimates for FY2025

Revise Downward

-2.47%

In Past 3 Month

Stock Price

Go Down

-5.41%

In Past 3 Month

6 Analyst Rating

Wall Street analysts forecast ATR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ATR is 165.60 USD with a low forecast of 133.00 USD and a high forecast of 220.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

4 Buy

2 Hold

0 Sell

Moderate Buy

Current: 0.000

Low

133.00

Averages

165.60

High

220.00

Current: 0.000

Low

133.00

Averages

165.60

High

220.00

Wells Fargo

Overweight -> Equal Weight

downgrade

$133

2026-01-06

New

Reason

Wells Fargo

Price Target

$133

2026-01-06

New

downgrade

Overweight -> Equal Weight

Reason

Wells Fargo downgraded AptarGroup to Equal Weight from Overweight with a $133 price target. The firm says that while 2025 turned into a more challenging year than it originally expected, Wells is still waiting for a catalyst that will drive a rebound. K-shaped economy remains the firm's top concern as low-end consumer health remains poor. For AptarGroup, Wells sees lack of catalysts to outrun sluggish start of year fundamentals.

BofA

George Staphos

Neutral

downgrade

$158 -> $142

2026-01-05

New

Reason

BofA

George Staphos

Price Target

$158 -> $142

2026-01-05

New

downgrade

Neutral

Reason

BofA analyst George Staphos lowered the firm's price target on AptarGroup to $142 from $158 and keeps a Neutral rating on the shares. The firm likes Aptar over the long term, given solid positioning in Pharma dispensing. That said, earnings trends could be impacted in the intermediate term by the slowdown in emergency medicine dispensing, litigation, continued weakness in China, and the sluggish profit trend in Beauty, the analyst tells investors in a research note.

Baird

Ghansham Panjabi

Outperform -> NULL

downgrade

$160 -> $145

2025-11-03

Reason

Baird

Ghansham Panjabi

Price Target

$160 -> $145

2025-11-03

downgrade

Outperform -> NULL

Reason

Baird analyst Ghansham Panjabi lowered the firm's price target on AptarGroup to $145 from $160 and keeps an Outperform rating on the shares. The firm updated its model following Q3 results and said the long-termstory remains intact.

Wells Fargo

Overweight

downgrade

$152 -> $133

2025-11-03

Reason

Wells Fargo

Price Target

$152 -> $133

2025-11-03

downgrade

Overweight

Reason

Wells Fargo lowered the firm's price target on AptarGroup to $133 from $152 and keeps an Overweight rating on the shares. The firm says that overshadowing a respectable Q3 performance was AptarGroup's warning of a high-margin product hitting an air pocket after tremendous growth since 2023. Though this drives Wells' lowered estimates, the firm sees the medium- and long-term story as intact.

William Blair

Matt Larew

Outperform -> Market Perform

downgrade

2025-11-01

Reason

William Blair

Matt Larew

Price Target

2025-11-01

downgrade

Outperform -> Market Perform

Reason

William Blair analyst Matt Larew downgraded AptarGroup to Market Perform from Outperform without a price target. The company reported "mixed" Q3 results and its Q4 earnings guidance was well below consensus, the analyst tells investors in a research note. The firm believes AptarGroup's growth over at least the next three quarters "is likely to be muted," with its profitability under pressure due to mix shift dynamics. Without a compression of the Narcan normalization timeline or improvement in beauty and closures, the stock setup "looks challenging over the next several quarters," contends Blair.

Wells Fargo

Overweight

maintain

$153 -> $152

2025-09-10

Reason

Wells Fargo

Price Target

$153 -> $152

2025-09-10

maintain

Overweight

Reason

Wells Fargo lowered the firm's price target on AptarGroup to $152 from $153 and keeps an Overweight rating on the shares after the company hosted its biennial Investor Day, where it showcased its innovation and product pipeline. Despite some near-term headwinds, the long-term growth story remains intact with a best-in-class margin/balance sheet profile, the firm says.

Valuation Metrics

The current forward P/E ratio for Aptargroup Inc (ATR.N) is 22.18, compared to its 5-year average forward P/E of 27.56. For a more detailed relative valuation and DCF analysis to assess Aptargroup Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

5Y Average PE

27.56

Current PE

22.18

Overvalued PE

31.37

Undervalued PE

23.75

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

5Y Average EV/EBITDA

13.42

Current EV/EBITDA

11.11

Overvalued EV/EBITDA

14.75

Undervalued EV/EBITDA

12.08

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

2.45

Current PS

2.12

Overvalued PS

2.77

Undervalued PS

2.13

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

FCF Margin - %

N/A

Net Margin - %

N/A

ROIC

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress areBuying! The buying amount has increased149.23%over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

ATR News & Events

Events Timeline

No data

News

1.0

01-07Businesswire

AptarGroup Schedules 2026 Quarterly Conference Call Dates

9.5

01-07Newsfilter

Aptar Announces 2026 Quarterly Conference Call Schedule

9.5

01-07Yahoo Finance

Ave Maria Growth Fund Reports -0.48% Q3 Return, Underperforming S&P 500

People Also Watch

Frequently Asked Questions

What is Aptargroup Inc (ATR) stock price today?

The current price of ATR is 123.85 USD — it has increased 1.15 % in the last trading day.

What is Aptargroup Inc (ATR)'s business?

AptarGroup, Inc. is engaged in designing and manufacturing of drug and consumer product dosing, dispensing and protection technologies. The Company serves various end markets, including pharmaceutical, beauty, food, beverage, personal care and home care. It operates in three segments. The Aptar Pharma segment sells proprietary dispensing systems, drug delivery systems, sealing solutions and services for the prescription drug, consumer health care, injectables, active material science solutions and digital health market. It also specializes in nasal drug delivery for delivering drugs. The Aptar Beauty segment sells dispensing systems and sealing solutions for the beauty, personal care and home care markets. The Aptar Closures segment sells dispensing systems, sealing solutions and food service trays to the food, beverage, personal care, home care, beauty and healthcare markets. This segment also includes the food protection business and the elastomeric flow-control technology business.

What is the price predicton of ATR Stock?

What is Aptargroup Inc (ATR)'s revenue for the last quarter?

Aptargroup Inc revenue for the last quarter amounts to 961.13M USD, increased 5.70 % YoY.

What is Aptargroup Inc (ATR)'s earnings per share (EPS) for the last quarter?

Aptargroup Inc. EPS for the last quarter amounts to 1.92 USD, increased 29.73 % YoY.

What changes have occurred in the market's expectations for Aptargroup Inc (ATR)'s fundamentals?

How many employees does Aptargroup Inc (ATR). have?

Aptargroup Inc (ATR) has 13500 emplpoyees as of January 10 2026.

What is Aptargroup Inc (ATR) market cap?

Today ATR has the market capitalization of 8.13B USD.